Mirco Bartolomei

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors

Lisa Bodei, Marta Cremonesi, Mahila Ferrari et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 413 citations

Urology, Renal Function, Medicine +10

Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study

Lisa Bodei, Marta Cremonesi, Chiara Maria Grana et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 411 citations

Engineering, Medicine, Radionuclide Therapy +11

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

Lisa Bodei, Marta Cremonesi, Stefania Zoboli et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2003 · 304 citations

Receptor-mediated Radionuclide Therapy, Engineering, Medicine +9

Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide

Giovanni Paganelli, Stefania Zoboli, Marta Cremonesi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2001 · 205 citations

Radiation Therapy, Radiopharmaceutical Therapy, Radiation Oncology +2

Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.

Concetta De Cicco, Marta Cremonesi, Alberto Luini et al. · PubMed · 1998 · 200 citations